Frontier’s dedicated participation was essential in helping GSK present data to the FDA establishing a favorable benefit of gepotidacin in adult and pediatric patients aged 12 and older with uUTI.
We’re excited to announce that TREMFYA is now FDA approved to treat Ulcerative Colitis (UC)! Clinical trials were conducted at our Uniontown site, and we are incredibly grateful to all the participants who contributed to making this treatment a reality to help improve the lives of many.
First blood test to be approved by FDA for primary CRC screening meets performance requirements for Medicare coverage and offers a more convenient option for millions of eligible individuals.
HOURS:
Monday – Friday
8:00 am – 4:30 pm
Appointments outside of business hours available by request
